每年研究成果
每年研究成果
研究成果
- 7 Article
- 7結果
搜尋結果
-
2023
Hepatic arterial infusion chemotherapy and immune checkpoint inhibitors, alone or in combination, in advanced hepatocellular carcinoma with macrovascular invasion: a single-centre experience in Taiwan
Wu, J. S., Hong, T. C., Wu, H-T., Lin, Y. J., Chang, T. T., Wang, C. T., Liu, W-C., Hsieh, M. T., Wu, I-C., Chen, P. J., Chen, C. Y., Lin, S-H., Chuang, C. H., Han, M. Z., Chen, H. P., Tsai, H-M. & Kuo, H. Y., 2023 4月 29, 於: Journal of Gastrointestinal Oncology. 14, 2, p. 849-862 14 p.研究成果: Article › 同行評審
開啟存取2 引文 斯高帕斯（Scopus） -
Multiple Field-of-View Based Attention Driven Network for Weakly Supervised Common Bile Duct Stone Detection
Chang, Y. H., Lin, M. Y., Hsieh, M. T., Ou, M-C., Huang, C. R. & Sheu, B-S., 2023, 於: IEEE Journal of Translational Engineering in Health and Medicine. 11, p. 394-404 11 p.研究成果: Article › 同行評審
開啟存取 -
Real-World Effectiveness of Sorafenib versus Lenvatinib Combined with PD-1 Inhibitors in Unresectable Hepatocellular Carcinoma
Chiang, H. C., Lee, Y. C., Chang, T. T., Lin, Y. J., Wu, H. T., Wang, C. T., Chen, C. Y., Chen, P. J., Hsieh, M. T., Lin, S. H., Chen, S. H., Chuang, C. H., Wu, I. C., Hong, T. C., Wu, J. S., Han, M. Z., Chen, W. T., Chiang, C. M., Hung, K. K. & Kuo, H. Y., 2023 2月, 於: Cancers. 15, 3, 854.研究成果: Article › 同行評審
開啟存取 -
The nonadherence and risk factors of eradication failure by sequential therapy as first-line anti-Helicobacter pylori treatment in real-world clinical practice
Lee, C-T., Wu, C-T., Chang, W-L., Yang, E-H., Hsieh, M-T., Chen, W-Y., Sheu, B. S. & Cheng, H-C., 2023, (Accepted/In press) 於: Helicobacter.研究成果: Article › 同行評審
-
2022
Endoscopic ultrasound avoids adverse events in high probability choledocholithiasis patients with a negative computed tomography
Lin, M. Y., Lee, C. T., Hsieh, M. T., Ou, M. C., Wang, Y. S., Lee, M. C., Chang, W. L. & Sheu, B. S., 2022 12月, 於: BMC Gastroenterology. 22, 1, 94.研究成果: Article › 同行評審
開啟存取1 引文 斯高帕斯（Scopus） -
Real-World Comparative Effectiveness of Nivolumab versus Pembrolizumab in Patients with Unresectable Hepatocellular Carcinoma
Kuo, H. Y., Han, M. Z., Liao, C. H., Lin, Y. J., Wang, C. T., Chen, S. H., Chang, T. T., Chen, P. J., Lin, S. H., Chen, C. Y., Chuang, C. H., Wu, I. C., Wu, J. S., Hong, T. C., Hsieh, M. T., Lee, Y. C., Wu, H. T. & Tsai, H. M., 2022 11月, 於: Pharmaceutics. 14, 11, 2263.研究成果: Article › 同行評審
開啟存取3 引文 斯高帕斯（Scopus） -
2020
Optimizing the MIC breakpoints of amoxicillin and tetracycline for antibiotic selection in the rescue therapy of H. pylori with bismuth quadruple regimen
Hsieh, M. T., Chang, W. L., Wu, C. T., Yang, H. B., Kuo, H. Y., Lin, M. Y., Cheng, H. C., Tsai, Y. C. & Sheu, B. S., 2020 11月 1, 於: European Journal of Clinical Pharmacology. 76, 11, p. 1581-1589 9 p.研究成果: Article › 同行評審
5 引文 斯高帕斯（Scopus）